The Impact of Liraglutide on Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease

Documenti analoghi

• Incidence of metabolic dysfunction‐associated steatotic liver disease and advanced fibrosis and impact of overweight/obesity in elderly population: a nationwide cohort study
  di: Kunhee Kim, et al.
  Pubblicazione: (2024)
• Diagnostic Value of MR Elastography and MRI‐Proton Density Fat Fraction in Cirrhosis Based on Explant Liver Histology
  di: Eun‐Ki Min, et al.
  Pubblicazione: (2026)
• Combined Impact of Triglyceride–Glucose Index and Alanine Aminotransferase on Steatotic Liver Disease and Subtypes
  di: Yu‐Jin Kwon, et al.
  Pubblicazione: (2026)
• Future Perspectives of Liver Research in the Asia‐Pacific Region: Focus on Hepatitis B and C
  di: Beom Kyung Kim
  Pubblicazione: (2025)
• Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy–Induced HBsAg Seroclearance
  di: Han Ah. Lee, et al.
  Pubblicazione: (2025)